Sahasra Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 106.83%
About Sahasra Laboratories
Sahasra Laboratories Private Limited (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 May 2006 and has a history of 18 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Giridhar Thota and Shobha Thota serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TG2006PTC050167
-
Company No.
050167
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 May 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sahasra Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Giridhar Thota
|
Director | 01-Jun-2006 | Current |
|
Shobha Thota
|
Director | 01-Jun-2006 | Current |
Financial Performance of Sahasra Laboratories.
Sahasra Laboratories Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sahasra Laboratories?
In 2017, Sahasra Laboratories had a promoter holding of 65.00% and a public holding of 35.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Spica Laboratories Private LimitedGiridhar Thota and Shobha Thota are mutual person
-
Shodhana Life Sciences Private LimitedGiridhar Thota is a mutual person
-
Shodhana Laboratories Private Limited
Shobha Thota is a mutual person
-
Medha Dyechem Pvt LtdGiridhar Thota and Shobha Thota are mutual person
-
Syngen Laboratories Private Limited
Giridhar Thota and Shobha Thota are mutual person
-
Sheetal Chemicals Private Limited
Giridhar Thota and Shobha Thota are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sahasra Laboratories?
Unlock and access historical data on people associated with Sahasra Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sahasra Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sahasra Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.